These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 23363368

  • 1. DEAD-box proteins, like Leishmania eIF4A, modulate interleukin (IL)-12, IL-10 and tumour necrosis factor-alpha production by human monocytes.
    Barhoumi M, Meddeb-Garnaoui A, Tanner NK, Banroques J, Kaabi B, Guizani I.
    Parasite Immunol; 2013; 35(5-6):194-9. PubMed ID: 23363368
    [Abstract] [Full Text] [Related]

  • 2. Leishmania infantum LeIF and its recombinant polypeptides modulate interleukin IL-12p70, IL-10 and tumour necrosis factor-α production by human monocytes.
    Barhoumi M, Garnaoui A, Kaabi B, Tanner NK, Guizani I.
    Parasite Immunol; 2011 Oct; 33(10):583-8. PubMed ID: 21793856
    [Abstract] [Full Text] [Related]

  • 3. Leishmania infantum LeIF protein is an ATP-dependent RNA helicase and an eIF4A-like factor that inhibits translation in yeast.
    Barhoumi M, Tanner NK, Banroques J, Linder P, Guizani I.
    FEBS J; 2006 Nov; 273(22):5086-100. PubMed ID: 17087726
    [Abstract] [Full Text] [Related]

  • 4. A Leishmania protein that modulates interleukin (IL)-12, IL-10 and tumor necrosis factor-alpha production and expression of B7-1 in human monocyte-derived antigen-presenting cells.
    Probst P, Skeiky YA, Steeves M, Gervassi A, Grabstein KH, Reed SG.
    Eur J Immunol; 1997 Oct; 27(10):2634-42. PubMed ID: 9368620
    [Abstract] [Full Text] [Related]

  • 5. A recombinant Leishmania antigen that stimulates human peripheral blood mononuclear cells to express a Th1-type cytokine profile and to produce interleukin 12.
    Skeiky YA, Guderian JA, Benson DR, Bacelar O, Carvalho EM, Kubin M, Badaro R, Trinchieri G, Reed SG.
    J Exp Med; 1995 Apr 01; 181(4):1527-37. PubMed ID: 7699334
    [Abstract] [Full Text] [Related]

  • 6. LeIF: a recombinant Leishmania protein that induces an IL-12-mediated Th1 cytokine profile.
    Skeiky YA, Kennedy M, Kaufman D, Borges MM, Guderian JA, Scholler JK, Ovendale PJ, Picha KS, Morrissey PJ, Grabstein KH, Campos-Neto A, Reed SG.
    J Immunol; 1998 Dec 01; 161(11):6171-9. PubMed ID: 9834103
    [Abstract] [Full Text] [Related]

  • 7. The steroid derivative 6-aminocholestanol inhibits the DEAD-box helicase eIF4A (LieIF4A) from the Trypanosomatid parasite Leishmania by perturbing the RNA and ATP binding sites.
    Abdelkrim YZ, Harigua-Souiai E, Barhoumi M, Banroques J, Blondel A, Guizani I, Tanner NK.
    Mol Biochem Parasitol; 2018 Dec 01; 226():9-19. PubMed ID: 30365976
    [Abstract] [Full Text] [Related]

  • 8. Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.
    Markikou-Ouni W, Drini S, Bahi-Jaber N, Chenik M, Meddeb-Garnaoui A.
    PLoS One; 2015 Dec 01; 10(11):e0143063. PubMed ID: 26581100
    [Abstract] [Full Text] [Related]

  • 9. Leishmania infantum LeIF and its recombinant polypeptides induce the maturation of dendritic cells in vitro: An insight for dendritic cells based vaccine.
    Barhoumi M, Koutsoni OS, Dotsika E, Guizani I.
    Immunol Lett; 2019 Jun 01; 210():20-28. PubMed ID: 30998957
    [Abstract] [Full Text] [Related]

  • 10. New Insights on the Adjuvant Properties of the Leishmania infantum Eukaryotic Initiation Factor.
    Koutsoni OS, Barhoumi M, Guizani I, Dotsika E.
    J Immunol Res; 2019 Jun 01; 2019():9124326. PubMed ID: 31183394
    [Abstract] [Full Text] [Related]

  • 11. Crystal structure of yeast initiation factor 4A, a DEAD-box RNA helicase.
    Caruthers JM, Johnson ER, McKay DB.
    Proc Natl Acad Sci U S A; 2000 Nov 21; 97(24):13080-5. PubMed ID: 11087862
    [Abstract] [Full Text] [Related]

  • 12. Codelivery of DNA vaccination encoding LeIF gene and IL-12 increases protection against Leishmania major infection in BALB/c mice.
    Maspi N, Ghaffarifar F, Sharifi Z, Dalimi A.
    Parasite Immunol; 2016 Apr 21; 38(4):228-35. PubMed ID: 26868280
    [Abstract] [Full Text] [Related]

  • 13. Crystallographic structure of the amino terminal domain of yeast initiation factor 4A, a representative DEAD-box RNA helicase.
    Johnson ER, McKay DB.
    RNA; 1999 Dec 21; 5(12):1526-34. PubMed ID: 10606264
    [Abstract] [Full Text] [Related]

  • 14. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
    Wanidworanun C, Strober W.
    J Immunol; 1993 Dec 15; 151(12):6853-61. PubMed ID: 8258695
    [Abstract] [Full Text] [Related]

  • 15. Monocyte induction of IL-10 and down-regulation of IL-12 by iC3b deposited in ultraviolet-exposed human skin.
    Yoshida Y, Kang K, Berger M, Chen G, Gilliam AC, Moser A, Wu L, Hammerberg C, Cooper KD.
    J Immunol; 1998 Dec 01; 161(11):5873-9. PubMed ID: 9834066
    [Abstract] [Full Text] [Related]

  • 16. Induction of intracellular cytokine production in human monocytes/macrophages stimulated with ligands of pattern recognition receptors.
    Mytar B, Gawlicka M, Szatanek R, Wołoszyn M, Ruggiero I, Piekarska B, Zembala M.
    Inflamm Res; 2004 Mar 01; 53(3):100-6. PubMed ID: 15021964
    [Abstract] [Full Text] [Related]

  • 17. Metacyclogenesis modulates the ability of Leishmania promastigotes to induce IL-12 production in human mononuclear cells.
    Sartori A, Oliveira MA, Scott P, Trinchieri G.
    J Immunol; 1997 Sep 15; 159(6):2849-57. PubMed ID: 9300708
    [Abstract] [Full Text] [Related]

  • 18. Intrinsic defects in macrophage IL-12 production associated with immune dysfunction in the MRL/++ and New Zealand Black/White F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain.
    Alleva DG, Kaser SB, Beller DI.
    J Immunol; 1998 Dec 15; 161(12):6878-84. PubMed ID: 9862720
    [Abstract] [Full Text] [Related]

  • 19. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE, Ng W, Wilson CB, McMaster WR, Burchett SK.
    J Clin Invest; 1990 Jun 15; 85(6):1914-24. PubMed ID: 2112157
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.